Due to the recent success of New Horizons in Amyloidosis, Radcliffe Cardiology are excited to introduce a new 2-day event ‘New Horizons in Cardiomyopathy’ (NHC) in February 2025.
The event, hosted on Radcliffe Cardiology, will be streamed on Tuesday 25 February - Wednesday 26 February 2025. It promises an interactive and informative experience, updating professionals on cardiac amyloidosis and cardiomyopathy diagnosis and treatment.
Day 1 will focus on hypertrophic cardiomyopathy (HCM), with a detailed exploration of HCM and an emphasis on emerging therapies and management strategies. Day 2 will focus on amyloidosis, providing a comprehensive update on the diagnosis and treatment of cardiac amyloidosis, along with insights into the latest research and clinical practices.
The course directors, Prof Rodney Falk (Brigham and Women’s Hospital, Boston, US), Prof Perry Elliott (University College London, UK), and Prof Marianna Fontana (University College London, UK), will lead a distinguished group of faculty members who are renowned experts in the field of cardiac amyloidosis. The faculty will encompass a diverse range of medical specialties, facilitating a comprehensive, multidisciplinary approach. This approach is designed to encourage collaboration and knowledge-sharing among healthcare professionals, ultimately enhancing the understanding and management of cardiac amyloidosis and cardiomyopathy.
Our aim is to provide a programme to educate healthcare professionals on the evolving management practices in cardiac amyloidosis and cardiomyopathy in an informal and engaging learning environment featuring thought-provoking presentations, cases and practical masterclasses.
Register now to gain essential insights and strategies on the diagnosis and treatment of cardiac amyloidosis and cardiomyopathy. We look forward to welcoming you.
*New Horizons in Cardiomyopathy’s programme has been submitted to the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) seeking 6 CME points, equating to 6 hours of learning.
(Please note this programme is subject to change)
Day 1 - Focus on Cardiomyopathy
Presentation and Discussion
Session 1: The Cardiomyopathy Mindset
Presentation of Case Study
Suspecting Cardiomyopathy
Overview of the Diagnostic Pathway
Presentation and Discussion
Session 2: The Diagnostic Pathway
Ventricular Morphology & Function
Additional Tests
Phenotyping
Presentation and Discussion
Session 3: The Management of Cardiomyopathy
Risk Stratification & Prognostic Assessment
The General Approach to Management
Management of Our Case Study: Hypertrophic Cardiomyopathy Patient
Day 2 - Focus on Amyloidosis
Presentation and Discussion
Session 1: Amyloidosis Specific Diagnosis
Presentation of Case Study: Clues for Amyloidosis
Amyloidosis Specific Investigations
Phenotyping & Genotyping
Discussion: New Horizons for Diagnosis
Presentation and Discussion
Session 2: Phenotypic Management Strategies
Managing AL Amyloidosis: What To Do in Relapse
Phenotypic ATTR Management
Presentation and Discussion
Session 3: The Treatment Horizon
Recent Data: Clinical & Real World
Key Overview of On-going Trials
The Reversal Debate
Perry Elliott
Course Director
University College London, London, UK
more info
Rodney Falk
Course Director
Brigham and Women's Hospital, Boston, US
more info
Marianna Fontana
Course Director
University College London, London, UK
more info
-
Increase the awareness of at-risk patients
-
Improve understanding of screening procedures
-
Provide guidance on the use of imaging for diagnosis
-
Improve awareness on current and emerging treatment
-
Provide guidance on initiating treatment and managing comorbidities
If you're interested in becoming a partner at NHC, please contact sales@radcliffe-group.com
Official Journal
Cardiac Failure Review (CFR) is an international, English language, peer-reviewed journal that publishes articles continually to CFRjournal.com and aims to assist time-pressured physicians to stay abreast of key advances and opinion in the area of heart failure.
The journal comprises balanced and comprehensive review articles and original research written by leading authorities. The journal provides updates on a range of salient issues to support physicians in developing their knowledge and effectiveness in day-to-day clinical practice.
The journal endeavours to support the continuous medical education of specialist and general cardiologists and disseminate knowledge of the field to the wider cardiovascular community.
Partnership: CFR is the official journal of the Italian Heart Failure Association (ITAHFA).
Journal website: www.cfrjournal.com
About Radcliffe Cardiology
We are Radcliffe, a knowledge network for the cardiovascular community
We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.
We bring medical knowledge to life
From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.
Our work is underpinned by 3 core principles:
- We build on the best science
- We work hands-on with our community
- We bring fresh thinking
Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.
For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com